Cure My Disease

Don't miss your cure!

 Log in / Sign up

Ancient cupping therapy put to the test for ringing ears

NCT ID NCT07685171

Symptom relief Sponsor: Hamad Medical Corporation Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 06, 2026 · Last updated Jul 07, 2026 · Updated 1 time

Summary

This study investigates whether wet cupping therapy can help adults with chronic subjective tinnitus (persistent ringing or buzzing in the ears). Participants aged 21 to 65 with tinnitus lasting over six months are randomly assigned to receive either wet cupping plus usual care or usual care alone. The main goal is to see if cupping reduces tinnitus-related handicap, with hearing changes and safety also tracked.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Wet cupping therapy
What this could lead to
If effective, wet cupping could offer a drug-free option to reduce tinnitus-related distress and improve quality of life.
What could go wrong
This is a mid-sized trial, and previous evidence is limited. The therapy may not outperform usual care, and side effects like bruising or infection are possible.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 142 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Jul 2026

An estimate. Start dates often move.

Expected to finish

Jul 2029

An estimate. End dates often move.

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

21 to 65 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Adults aged 21 to 65 years old. * Primary subjective tinnitus with or without hearing loss for more than 6 months. * Tinnitus significantly impacting quality of life, as measured by the Tinnitus Handicap Inventory (THI). Exclusion Criteria: * Objective, acute or intermittent tinnitus. * History of Ménière's disease. * Tinnitus induced by cerebellopontine angle tumors. * Cardiovascular disease, or a serious medical or mental illness. * History of central nervous system disease. * Patient with anemia or cardiovascular diseases. * Current pregnancy or breast-feeding. * Patients with a lack of willingness or availability.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Cupping therapy are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

tinnitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Cupping therapy Tinnitus, subjective

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  2. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

More trials for these conditions

Other studies related to the condition(s) this trial covers.